Ampio Pharmaceuticals
(AMPE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,089 | 12,653 | 33,892 | 17,346 | 6,532 |
| Receivables | 920 | N/A | N/A | N/A | N/A |
| TOTAL | $5,736 | $13,329 | $35,632 | $18,493 | $8,250 |
| Non-Current Assets | |||||
| PPE Net | N/A | 184 | 2,564 | 3,561 | 4,748 |
| Other Non-Current Assets | 0 | 75 | 629 | 824 | 1,003 |
| TOTAL | $N/A | $259 | $3,193 | $4,385 | $5,751 |
| Total Assets | $5,736 | $13,588 | $38,825 | $22,878 | $14,001 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,102 | 852 | 4,811 | 1,550 | 4,025 |
| TOTAL | $2,376 | $1,192 | $5,122 | $1,834 | $4,284 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 607 | 6,419 | 3,532 | 3,274 |
| TOTAL | $N/A | $607 | $6,419 | $3,532 | $3,274 |
| Total Liabilities | $2,376 | $1,799 | $11,541 | $5,366 | $7,558 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,135 | 755 | 758 | 652 | 530 |
| Common Shares | N/A | N/A | 2 | 19 | 16 |
| Retained earnings | -242,527 | -233,939 | -217,602 | -200,527 | -184,633 |
| TOTAL | $3,360 | $11,789 | $27,284 | $17,512 | $6,443 |
| Total Liabilities And Equity | $5,736 | $13,588 | $38,825 | $22,878 | $14,001 |